Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with ...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density ...
Healio

Anabolic, antiresorptive agents the 'ideal one-two punch' for osteoporosis

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Patients with osteoporosis may benefit from treatment initiation with an anabolic agent followed ...